Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Innovative catheter-guidewire

Reference number
Coordinator Cavis Technologies AB
Funding from Vinnova SEK 1 805 000
Project duration December 2017 - November 2022
Status Completed

Purpose and goal

** Denna text är maskinöversatt ** The purpose is to show a pressure conductor with better properties and better measuring precision than competing products. The goal is to get the product CE approved.

Expected results and effects

** Denna text är maskinöversatt ** All the tests we have performed have shown that our product meets the eligibility requirements we wanted to achieve. Now the product is CE approved and the first clinical evaluation has been carried out, which shows that the product has a unique precision and is safe and efficient to use.

Planned approach and implementation

** Denna text är maskinöversatt ** The product underwent a number of rigorous tests before CE marking. Results were reviewed by the Notified body and the Swedish Medicines Agency, as the product is a drug/device combination product. Due to Covid-19, the hospitals had a ban on visitors to their labs and had to make other priorities, which led to delays before the study started. Sahlgrenska Universitetssjukhuset conducted the study.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 17 November 2022

Reference number 2017-04692

Page statistics